BE678366A - - Google Patents
Info
- Publication number
- BE678366A BE678366A BE678366DA BE678366A BE 678366 A BE678366 A BE 678366A BE 678366D A BE678366D A BE 678366DA BE 678366 A BE678366 A BE 678366A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC036759 | 1965-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE678366A true BE678366A (en:Method) | 1966-09-26 |
Family
ID=7433992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE678366D BE678366A (en:Method) | 1965-03-24 | 1966-03-24 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3541209A (en:Method) |
| BE (1) | BE678366A (en:Method) |
| FR (1) | FR5425M (en:Method) |
| GB (1) | GB1126892A (en:Method) |
| NL (1) | NL151903B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9827727D0 (en) | 1998-12-16 | 1999-02-10 | Pfizer Ltd | Antiparasitic formulations |
| GB0000313D0 (en) | 2000-01-10 | 2000-03-01 | Astrazeneca Uk Ltd | Formulation |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| AU2016284459B2 (en) | 2015-06-22 | 2021-12-23 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1074582B (de) * | 1960-02-04 | Schering Aktiengesellschaft, Ber Im | Verfahren zur Herstellung progesteronartig wirksamer Steroide mit bisher unerreichter Hohe der Wirksamkeit | |
| GB876902A (en) * | 1957-03-09 | 1961-09-06 | Syntex Sa | New cyclopentanophenanthrene derivatives and process for the production thereof |
-
1966
- 1966-03-23 NL NL666603833A patent/NL151903B/xx not_active IP Right Cessation
- 1966-03-24 BE BE678366D patent/BE678366A/xx not_active IP Right Cessation
- 1966-03-24 FR FR54844A patent/FR5425M/fr not_active Expired
- 1966-03-24 GB GB13103/66A patent/GB1126892A/en not_active Expired
-
1967
- 1967-10-12 US US675003A patent/US3541209A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NL6603833A (en:Method) | 1966-09-26 |
| GB1126892A (en) | 1968-09-11 |
| NL151903B (nl) | 1977-01-17 |
| US3541209A (en) | 1970-11-17 |
| FR5425M (en:Method) | 1967-10-02 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: SCHERING A.G. Effective date: 19850324 |